Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$512,491
New position
Shares Held
29,302
first reported quarter
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STATE OF WISCONSIN INVESTMENT BOARD holds $146,075,839 across 40 Drug Manufacturers - Specialty & Generic names. BIOA ranks #31 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
236,309 | $27,934,086 | |
| 2 | VTRS |
Viatris Inc
|
1,529,115 | $20,658,343 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
96,261 | $12,681,424 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
21,326 | $12,645,891 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
361,622 | $10,892,054 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
126,437 | $9,590,246 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
313,166 | $7,494,062 | |
| 8 | ALKS |
Alkermes plc.
|
139,333 | $4,926,814 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $512,491 | 29,302 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||